[Laparoscopy for staging and treatment of cervical cancer].

Ginecol Obstet Mex

Departamento de Ginecología Oncológica, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social.

Published: May 2009

Background: Laparoscopic surgery for cervical cancer (CC) study and treatment is one of the main achievements in last years.

Objective: Describe the feasibility and experience of laparoscopic procedures for CC staging and treatment.

Patients And Method: A retrospective analysis of 75 patients with CC in different stages was done, group I included CC in situ patients treated with type I Piver hysterectomy, in group 2, patients with early CC treated with type II or III radical hysterectomy with pelvic lymphadenectomy and para-aortic lymph node sampling, and group 3 patients with locally advanced CC submitted to pelvic and para-aortic lymphadenectomy. We analyzed operating time, bleeding, hospital stay, conversion to laparotomy, late complications and tumor recurrence.

Results: Thirty patients were included in group 1, 31 in group 2 and 14 in group 3, mean operating time was 143, 270 and 136 minutes, bleeding 170, 460 and 80 mL, hospital stay was 1.6, 3.6 and 1.5 days and conversion to laparotomy was 3%, 9.7% and 0%, respectively for each group.

Conclusion: Laparoscopy is a safe procedure for the staging and treatment of cervical cancer in its different stages.

Download full-text PDF

Source

Publication Analysis

Top Keywords

staging treatment
8
treatment cervical
8
cervical cancer
8
treated type
8
group patients
8
operating time
8
hospital stay
8
conversion laparotomy
8
group group
8
group
6

Similar Publications

Background: Anaplastic thyroid cancer (ATC) is a highly lethal disease, often diagnosed with advanced locoregional and distant metastases, resulting in a median survival of just 3-5 months. This study determines the stratified effectiveness of baseline treatments in all combinations, enabling precise prognoses prediction and establishing benchmarks for advanced therapeutic options.

Methods: The study extracted a cohort of pathologically confirmed ATC patients from the Surveillance, Epidemiology, and End Results program.

View Article and Find Full Text PDF

Background: Tumor size (TS) in pancreatic ductal adenocarcinoma (PDAC) is one of the most important prognostic factors. However, discrepancies between TS on preoperative images (TSi) and pathological specimens (TSp) have been reported. This study aims to evaluate the factors associated with the differences between TSi and TSp.

View Article and Find Full Text PDF

Multi-class Classification of Retinal Eye Diseases from Ophthalmoscopy Images Using Transfer Learning-Based Vision Transformers.

J Imaging Inform Med

January 2025

College of Engineering, Department of Computer Engineering, Koç University, Rumelifeneri Yolu, 34450, Sarıyer, Istanbul, Turkey.

This study explores a transfer learning approach with vision transformers (ViTs) and convolutional neural networks (CNNs) for classifying retinal diseases, specifically diabetic retinopathy, glaucoma, and cataracts, from ophthalmoscopy images. Using a balanced subset of 4217 images and ophthalmology-specific pretrained ViT backbones, this method demonstrates significant improvements in classification accuracy, offering potential for broader applications in medical imaging. Glaucoma, diabetic retinopathy, and cataracts are common eye diseases that can cause vision loss if not treated.

View Article and Find Full Text PDF

Introduction: Kidney transplantation is the preferred treatment for end-stage kidney disease (ESKD), enhancing survival and quality of life. However, kidney transplant recipients (KTRs) are at high risk for bone disorders, particularly low bone turnover disease, which increases fracture risk. Teriparatide, an anabolic agent, may provide a beneficial treatment option for these patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!